Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CarthaGenetics
Pully, Vaud, Switzerlandcarthagenetics.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
CarthaGenetics is a Swiss-based consulting and service company specializing in the development and commercialization of orphan drugs and advanced therapies. Founded in 2004, the company focuses on the European, Turkish, and North African markets, providing expertise in patient identification, early access programs (EAPs), and regulatory strategy. They leverage a strong network of medical specialists to accelerate clinical trial enrollment and facilitate access to innovative treatments for rare genetic disorders. Additionally, CarthaGenetics offers specialized services for the development of orphan drug biosimilars in regions where market exclusivity does not apply.
- Therapeutic areas
- HematologyNeurologyRare DiseasesMetabolic DisordersOncology
- Modalities
- BiologicCell therapyGene therapyProtein
- Industry
- Contract Research Organization
02
Partnerships
Beyond the preview
Go deeper on CarthaGenetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CarthaGenetics.